Lillian Ting
YOU?
Author Swipe
View article: P09 Aztreonam and avibactam synergy for MBL-producing Enterobacterales and patient clinical outcomes in a large UK hospital trust
P09 Aztreonam and avibactam synergy for MBL-producing Enterobacterales and patient clinical outcomes in a large UK hospital trust Open
Background Antimicrobial resistance presents a continuously evolving global challenge, with significant resources devoted to treating infections caused by MDR organisms. Certain resistance mechanisms, such as Class B β-lactamases, includin…
View article: Diagnosis of Mycoplasma-Induced Rash with Mucositis (MIRM) Mimicking Steven Johnson Syndrome (SJS) in Children as a New Entity: A Case Report
Diagnosis of Mycoplasma-Induced Rash with Mucositis (MIRM) Mimicking Steven Johnson Syndrome (SJS) in Children as a New Entity: A Case Report Open
Mycoplasma pneumoniae (MP) is a pathogen commonly associated with respiratory illnesses. It accounts for about 40% of community-acquired pneumonia (CAP) cases, and approximately 25% of cases exhibit extrapulmonary manifestations, affecting…
View article: An Open-Label Study of the Impact of Hepatic Impairment on the Pharmacokinetics and Safety of Single Oral and Intravenous Doses of Omadacycline
An Open-Label Study of the Impact of Hepatic Impairment on the Pharmacokinetics and Safety of Single Oral and Intravenous Doses of Omadacycline Open
Omadacycline is a once-daily oral or intravenous (i.v.) aminomethylcycline antibiotic approved in the United States for the treatment of community-acquired bacterial pneumonia (CABP) and acute bacterial skin and skin structure infections (…
View article: Randomized, Open-Label Study of the Pharmacokinetics and Safety of Oral and Intravenous Administration of Omadacycline to Healthy Subjects
Randomized, Open-Label Study of the Pharmacokinetics and Safety of Oral and Intravenous Administration of Omadacycline to Healthy Subjects Open
Omadacycline is a first-in-class aminomethylcycline antibiotic with microbiological activity against Gram-positive and Gram-negative aerobes and anaerobes and atypical bacteria that is being developed for the treatment of acute bacterial s…
View article: Clinical disposition, metabolism and<i>in vitro</i>drug–drug interaction properties of omadacycline
Clinical disposition, metabolism and<i>in vitro</i>drug–drug interaction properties of omadacycline Open
1. Absorption, distribution, metabolism, transport and elimination properties of omadacycline, an aminomethylcycline antibiotic, were investigated in vitro and in a study in healthy male subjects. 2. Omadacycline was metabolically stable i…